Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Regadenoson Real Time Perfusion Imaging Trial

NCT00837369 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT00837369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00837369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Regadenoson Real Time Perfusion Imaging Trial
Lead sponsor
University of Nebraska
Phase
Phase 1
Overall status
Completed
Start date
April 7, 2009
Completion date
December 1, 2011
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, myocardial perfusion abnormalities